3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
12
Ovarian Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Fallopian Tube Neoplasms
6
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Carcinoma, Renal Cell
4
Triple Negative Breast Neoplasms
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Glioblastoma
3
Endometrial Neoplasms
3
Cholangiocarcinoma
3
Breast Neoplasms
3
Thyroid Neoplasms
2
Small Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Carcinoma
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell
2
Lymphoid Interstitial Pneumonia
2
Liposarcoma
2
Interventions
Vincristine
8
X-Rays
6
Temozolomide
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Cyclophosphamide
6
Specimen Handling
5
Irinotecan
5
Nuclear Medicine Department, Hospital
4
Biopsy
4
Radiotherapy
3
Radiation
3
Dactinomycin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
ensartinib
2
Vinorelbine
2
Proton Therapy
2
LY3023414
2
Ifosfamide
2
Filgrastim
2
Etoposide
2
Doxorubicin
2
Dexrazoxane
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Immunoglobulin G
×
90 days
×
Clear all
No trials found.